Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection
- PMID: 33813426
- DOI: 10.21873/anticanres.14987
Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection
Abstract
Background/aim: Inflammation-based prognostic scores are proven prognostic biomarkers in various cancers. This study aimed to identify a useful prognostic score for patients with biliary tract cancer (BTC) after surgical resection.
Patients and methods: This retrospective study recruited 115 patients with BTC during 2010-2020. The relationship between clinicopathological variables, including various prognostic scores and overall survival (OS), was investigated using univariate and multivariate analyses.
Results: BTC included 58 cholangiocarcinoma, 29 gallbladder carcinoma, 16 ampullary carcinoma, and 12 perihilar cholangiocarcinoma cases. A significant difference was detected in OS of patients with a Japanese modified Glasgow prognostic score (JmGPS) 0 (n=62) and JmGPS 1 or 2 (high JmGPS) (n=53). In the multivariate analysis, tumour differentiation (p=0.014) and a high JmGPS (p=0.047) were independent prognostic factors.
Conclusion: The high JmGPS was an independent prognostic predictor after surgical resection and was superior to other prognostic scores.
Keywords: Biliary tract cancer; inflammation-based prognostic score; modified Glasgow prognostic score; prognosis.
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Similar articles
-
Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.Eur J Surg Oncol. 2020 May;46(5):804-810. doi: 10.1016/j.ejso.2019.12.008. Epub 2019 Dec 14. Eur J Surg Oncol. 2020. PMID: 31848078
-
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.Cancer Chemother Pharmacol. 2009 Dec;65(1):113-20. doi: 10.1007/s00280-009-1011-z. Epub 2009 Apr 29. Cancer Chemother Pharmacol. 2009. PMID: 19404641 Clinical Trial.
-
Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort.Hepatology. 2021 Oct;74(4):1994-2006. doi: 10.1002/hep.31879. Epub 2021 Jul 20. Hepatology. 2021. PMID: 33942350 Free PMC article.
-
[Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder].Z Gastroenterol. 2005 Mar;43(3):305-15. doi: 10.1055/s-2004-813319. Z Gastroenterol. 2005. PMID: 15765304 Review. German.
-
[The effect of R1 resection in the hepatobiliary pancreatic system].Chirurg. 2007 Sep;78(9):802-9. doi: 10.1007/s00104-007-1377-6. Chirurg. 2007. PMID: 17680231 Review. German.
Cited by
-
Preoperative Myosteatosis and Prognostic Nutritional Index Predict Survival in Older Patients With Resected Biliary Tract Cancer.Cancer Diagn Progn. 2024 Mar 3;4(2):147-156. doi: 10.21873/cdp.10301. eCollection 2024 Mar-Apr. Cancer Diagn Progn. 2024. PMID: 38434914 Free PMC article.
-
Prognostic Significance of Lymphocyte-to-Monocyte Ratio in Patients With Unresectable Biliary Tract Cancer Undergoing Systemic Chemotherapy.Cancer Diagn Progn. 2025 Jan 3;5(1):132-137. doi: 10.21873/cdp.10422. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758246 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources